JOA - 2026-11-11 - Journal Article
Preoperative Opioid Use Predicts Socioeconomic Vulnerability and Worse Recovery in Elective Total Joint Arthroplasty.
Barkus O, Zamzam M, Hodson N, Pang A, Lachman C, North WT, Charters M
Topics
Key Takeaway
Preoperative opioid prescription (present in 36.8% of 10,679 TJA patients) independently predicted PE (OR 3.47), return to OR (OR 6.68), PJI (OR 3.07), non-home discharge (OR 2.07), and failure to achieve SCB on KOOS-JR in TKA.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This retrospective cohort examined associations between an active opioid prescription within 30 days of primary THA or TKA and 90-day complications, LOS, discharge disposition, 1-year PROMs, and Social Vulnerability Index scores across 10,679 patients from 2018–2023. Preoperative opioid prescription was present in 36.8% and independently associated with PE (OR 3.47), PJI (OR 3.07), return to OR (OR 6.68), non-home discharge (OR 2.07), longer LOS (IRR 1.24–1.25), and reduced KOOS-JR improvement (adjusted mean difference -2.44) with lower odds of achieving SCB (OR 0.72) in TKA. Higher Social Vulnerability Index scores were independently associated with preoperative opioid prescription, linking socioeconomic disadvantage to this high-risk phenotype.
Key Limitation
Prescription-based opioid definition cannot confirm actual consumption, and the absence of morphine milligram equivalent (MME) dosing data prevents dose-response analysis that would clarify whether risk is threshold-dependent.
Original Abstract
INTRODUCTION
Preoperative opioid prescription may be associated with postoperative outcomes after total joint arthroplasty (TJA). We conducted a retrospective cohort study of patients who underwent primary TJA to assess associations between an active preoperative opioid prescription and 90-day complications, lengths of stay (LOS), discharge disposition, one-year patient-reported outcome measures (PROMs), and socioeconomic vulnerability.
METHODS
We identified 10,679 patients who underwent primary total hip arthroplasty (THA) or total knee arthroplasty (TKA) from 2018 to 2023. Preoperative opioid use was defined as an active opioid prescription within one month before surgery. This prescription-based definition served as a proxy for opioid exposure and did not confirm that prescriptions were filled or consumed. Outcomes included 90-day complications, LOS, discharge disposition, attainment of substantial clinical benefit (SCB) on PROMs collected from 2021 to 2023, and social vulnerability measured by the Social Vulnerability Index (SVI). Univariate analyses were used to identify candidate variables for multivariable logistic and negative binomial regression models.
RESULTS
Preoperative opioid prescription was identified in 3,935 patients (36.8%). Higher social vulnerability was independently associated with preoperative opioid prescription. In TKA, opioid prescription was independently associated with non-home discharge (odds ratio [OR] 2.07), pulmonary embolism (OR 3.47), longer length of stay (incidence rate ratio [IRR] 1.24), longer procedure duration (IRR 1.05), smaller improvements in the Knee injury and Osteoarthritis Outcome Score for Joint Replacement (adjusted mean difference -2.44), and lower odds of SCB (OR 0.72). In THA, opioid prescription was independently associated with return to the operating room (OR 6.68), periprosthetic joint infection (OR 3.07), and longer postoperative stay (IRR 1.25).
CONCLUSION
Preoperative opioid prescription was common and was associated with worse outcomes in this TJA cohort. Patients who had a preoperative opioid prescription experienced longer LOS, more frequent non-home discharge, and reduced functional improvement after TKA. Opioid prescription was also correlated with greater socioeconomic vulnerability. Because no intervention was evaluated, these findings identify preoperative opioid prescription and socioeconomic vulnerability as markers of a higher-risk group rather than demonstrating that addressing either one reduces risk.